Recent reports have demonstrated that high NCL expression promotes drug resistance in acute lymphoblastic leukemia [12].These results indicate that NCL may be involved in drug resistance of tumor cells, but whether NCL is involved in cisplatin resistance in cervical cancer has not been reported. This evidence concerns the gene NUCLEOLIN and acute lymphoblastic leukemia.